IDEAS home Printed from https://ideas.repec.org/a/spr/eujhec/v19y2018i8d10.1007_s10198-018-0963-5.html
   My bibliography  Save this article

How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts

Author

Listed:
  • Simon Wieser

    (Zurich University of Applied Sciences)

  • Marco Riguzzi

    (Zurich University of Applied Sciences)

  • Mark Pletscher

    (Zurich University of Applied Sciences)

  • Carola A. Huber

    (Helsana Insurance Group)

  • Harry Telser

    (Polynomics)

  • Matthias Schwenkglenks

    (University of Zurich)

Abstract

In most countries, surprisingly little is known on how national healthcare spending is distributed across diseases. Single-disease cost-of-illness studies cover only a few of the diseases affecting a population and in some cases lead to untenably large estimates. The objective of this study was to decompose healthcare spending in 2011, according to Swiss National Health Accounts, into 21 collectively exhaustive and mutually exclusive major disease categories. Diseases were classified following the Global Burden of Disease Study. We first assigned the expenditures directly mapping from National Health Accounts to the 21 diseases. The remaining expenditures were assigned based on diagnostic codes and clues contained in a variety of microdata sources. Expenditures were dominated by non-communicable diseases with a share of 79.4%. Cardiovascular diseases stood out with 15.6% of total spending, followed by musculoskeletal disorders (13.4%), and mental and substance use disorders (10.6%). Neoplasms (6.0% of the total) ranked only sixth, although they are the leading cause of premature death in Switzerland. These results may be useful for the design of health policies, as they illustrate how healthcare spending is influenced by the epidemiological transition and increasing life expectancy. They also provide a plausibility check for single cost-of-illness studies. Our study may serve as a starting point for further research on the drivers of the constant growth of healthcare spending.

Suggested Citation

  • Simon Wieser & Marco Riguzzi & Mark Pletscher & Carola A. Huber & Harry Telser & Matthias Schwenkglenks, 2018. "How much does the treatment of each major disease cost? A decomposition of Swiss National Health Accounts," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(8), pages 1149-1161, November.
    • Handle: RePEc:spr:eujhec:v:19:y:2018:i:8:d:10.1007_s10198-018-0963-5
    DOI: 10.1007/s10198-018-0963-5
    as

    Download full text from publisher

    File URL: http://link.springer.com/10.1007/s10198-018-0963-5
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1007/s10198-018-0963-5?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Heijink, Richard & Noethen, Manuela & Renaud, Thomas & Koopmanschap, Marc & Polder, Johan, 2008. "Cost of illness: An international comparison: Australia, Canada, France, Germany and The Netherlands," Health Policy, Elsevier, vol. 88(1), pages 49-61, October.
    2. Eberechukwu Onukwugha & Jacquelyn McRae & Alex Kravetz & Stefan Varga & Rahul Khairnar & C. Mullins, 2016. "Cost-of-Illness Studies: An Updated Review of Current Methods," PharmacoEconomics, Springer, vol. 34(1), pages 43-58, January.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Eggli, Yves & Stadelmann, Pierre & Piaget-Rossel, Romain & Marti, Joachim, 2019. "Heterogeneity in The drivers of health expenditures financed by health insurance in a fragmented health system: The case of Switzerland," Health Policy, Elsevier, vol. 123(12), pages 1275-1281.
    2. Nicolet, Anna & Perraudin, Clémence & Krucien, Nicolas & Wagner, Joël & Peytremann-Bridevaux, Isabelle & Marti, Joachim, 2023. "Preferences of older adults for healthcare models designed to improve care coordination: Evidence from Western Switzerland," Health Policy, Elsevier, vol. 132(C).
    3. Indrani Gupta & Avantika Ranjan, 2019. "Public expenditure on Non-Communicable Diseases & Injuries in India: A budget-based analysis," PLOS ONE, Public Library of Science, vol. 14(9), pages 1-12, September.
    4. Fiorella Pia Salvatore & Alessia Spada & Francesca Fortunato & Demetris Vrontis & Mariantonietta Fiore, 2021. "Identification of Health Expenditures Determinants: A Model to Manage the Economic Burden of Cardiovascular Disease," IJERPH, MDPI, vol. 18(9), pages 1-15, April.
    5. Babashahi, Saeideh & Hansen, Paul & Sullivan, Trudy, 2021. "Creating a priority list of non-communicable diseases to support health research funding decision-making," Health Policy, Elsevier, vol. 125(2), pages 221-228.
    6. Michael Stucki, 2021. "Factors related to the change in Swiss inpatient costs by disease: a 6-factor decomposition," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(2), pages 195-221, March.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Son Nghiem & Rasheda Khanam & Xuan-Binh Vu & Bach Xuan Tran, 2020. "Implicitly Estimating the Cost of Mental Illness in Australia: A Standard-of-Living Approach," Applied Health Economics and Health Policy, Springer, vol. 18(2), pages 261-270, April.
    2. Beata Gavurova & Miriama Tarhanicova, 2021. "Methods for Estimating Avoidable Costs of Excessive Alcohol Consumption," IJERPH, MDPI, vol. 18(9), pages 1-25, May.
    3. Bugge, Christoffer & Sæther, Erik Magnus & Brustugun, Odd Terje & Kristiansen, Ivar Sønbø, 2021. "Societal cost of cancer in Norway –Results of taking a broader cost perspective," Health Policy, Elsevier, vol. 125(8), pages 1100-1107.
    4. Valentin Brodszky & Zsuzsanna Beretzky & Petra Baji & Fanni Rencz & Márta Péntek & Alexandru Rotar & Konstantin Tachkov & Susanne Mayer & Judit Simon & Maciej Niewada & Rok Hren & László Gulácsi, 2019. "Cost-of-illness studies in nine Central and Eastern European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 155-172, June.
    5. Błażej Łyszczarz, 2019. "Production Losses Associated with Alcohol-Attributable Mortality in the European Union," IJERPH, MDPI, vol. 16(19), pages 1-14, September.
    6. Leslie Wilson & Jie Ting & Harold Lin & Rahil Shah & Michael MacLean & Michael W. Peterson & Nathan Stockamp & Robert Libke & Paul Brown, 2019. "The Rise of Valley Fever: Prevalence and Cost Burden of Coccidioidomycosis Infection in California," IJERPH, MDPI, vol. 16(7), pages 1-16, March.
    7. Grégoire Lagasnerie & Anne-Sophie Aguadé & Pierre Denis & Anne Fagot-Campagna & Christelle Gastaldi-Menager, 2018. "The economic burden of diabetes to French national health insurance: a new cost-of-illness method based on a combined medicalized and incremental approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 19(2), pages 189-201, March.
    8. M. Lette & W. Bemelmans & J. Breda & L. Slobbe & J. Dias & H. Boshuizen, 2016. "Health care costs attributable to overweight calculated in a standardized way for three European countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 17(1), pages 61-69, January.
    9. Allison Larg & John Moss, 2011. "Cost-of-Illness Studies," PharmacoEconomics, Springer, vol. 29(8), pages 653-671, August.
    10. Pieter van Baal & Meg Perry‐Duxbury & Pieter Bakx & Matthijs Versteegh & Eddy van Doorslaer & Werner Brouwer, 2019. "A cost‐effectiveness threshold based on the marginal returns of cardiovascular hospital spending," Health Economics, John Wiley & Sons, Ltd., vol. 28(1), pages 87-100, January.
    11. Elena Cottini & Claudio Lucifora, 2013. "Mental Health and Working Conditions in Europe," ILR Review, Cornell University, ILR School, vol. 66(4), pages 958-988, July.
    12. Fiorella Pia Salvatore & Alessia Spada & Francesca Fortunato & Demetris Vrontis & Mariantonietta Fiore, 2021. "Identification of Health Expenditures Determinants: A Model to Manage the Economic Burden of Cardiovascular Disease," IJERPH, MDPI, vol. 18(9), pages 1-15, April.
    13. Kanters, Tim A. & Brouwer, Werner B.F. & van Vliet, René C.J.A. & van Baal, Pieter H.M. & Polder, Johan J., 2013. "A new prevention paradox: The trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers," Social Science & Medicine, Elsevier, vol. 76(C), pages 150-158.
    14. Wubulihasimu, Parida & Gheorghe, Maria & Slobbe, Lany & Polder, Johan & van Baal, Pieter, 2015. "Trends in Dutch hospital spending by age and disease 1994–2010," Health Policy, Elsevier, vol. 119(3), pages 316-323.
    15. Richard Heijink & Xander Koolman & Gert Westert, 2013. "Spending more money, saving more lives? The relationship between avoidable mortality and healthcare spending in 14 countries," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 14(3), pages 527-538, June.
    16. Albert Wong & Pieter H. M. van Baal & Hendriek C. Boshuizen & Johan J. Polder, 2011. "Exploring the influence of proximity to death on disease‐specific hospital expenditures: a carpaccio of red herrings," Health Economics, John Wiley & Sons, Ltd., vol. 20(4), pages 379-400, April.

    More about this item

    Keywords

    Healthcare expenditures; Cost-of-illness; Healthcare costs; National Health Accounts; Switzerland; Decomposition by diseases;
    All these keywords.

    JEL classification:

    • I10 - Health, Education, and Welfare - - Health - - - General
    • I11 - Health, Education, and Welfare - - Health - - - Analysis of Health Care Markets

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:eujhec:v:19:y:2018:i:8:d:10.1007_s10198-018-0963-5. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.